A panel of biomarkers in the prediction for early allograft dysfunction and mortality after living donor liver transplantation.

Tsai, Hsin-I; Lo, Chi-Jen; Lee, Chao-Wei; Lin, Jr-Rung; Lee, Wei-Chen; Ho, Hung-Yao; Tsai, Chia-Yi; Cheng, Mei-Ling; Yu, Huang-Ping

Tsai, Hsin-I; Lo, Chi-Jen; Lee, Chao-Wei; Lin, Jr-Rung; Lee, Wei-Chen; Ho, Hung-Yao; Tsai, Chia-Yi; Cheng, Mei-Ling; Yu, Huang-Ping.

Afiliación

Tsai HI; Department of Anesthesiology, Chang Gung Memorial Hospital Taoyuan 333, Taiwan.
Lo CJ; College of Medicine, Chang Gung University Taoyuan 333, Taiwan.
Lee CW; Metabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University Taoyuan 333, Taiwan.
Lin JR; College of Medicine, Chang Gung University Taoyuan 333, Taiwan.
Lee WC; Department of General Surgery, Chang Gung Memorial Hospital Taoyuan 333, Taiwan.
Ho HY; Clinical Informatics and Medical Statistics Research Center and Graduate Institute of Clinical Medicine, Chang Gung University Taoyuan 333, Taiwan.
Tsai CY; Department of General Surgery, Chang Gung Memorial Hospital Taoyuan 333, Taiwan.
Cheng ML; Department of Liver and Transplantation Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine Taoyuan 333, Taiwan.
Yu HP; Metabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University Taoyuan 333, Taiwan.

Am J Transl Res ; 13(1): 372-382, 2021.

Article en En | MEDLINE | ID: mdl-33527031

Palabras clave

Lipidomics; betaine; early allograft dysfunction; living donor liver transplantation; lysophosphatidylcholines; phosphatidylcholines

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Transl Res Año: 2021 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google